NIRTEK was formed to prevent heart attacks and save lives by detecting unstable coronary plaques using a patented technology known as Near Infra-Red Auto Fluorescence (NIRAF) so they can be treated before they lead to major adverse cardiovascular events, the leading cause of death worldwide.
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2020 (6 years)
Address:
75 COMMERCIAL ROAD; MELBOURNE, VICTORIA 3004, AU
LOW
spending power
